Stanford University
Showing 18,651-18,700 of 34,998 Results
-
Daphne P. Ly, MD, FACS
Affiliate
Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
2. Apply Cancer Genetics in cancer treatment and cancer risk reduction. -
Deirdre J. Lyell, M.D.
Dunlevie Endowed Professor of Maternal-Fetal Medicine and Professor, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPreterm labor prevention and management, preeclampsia prevention and treatment, short and long-term impact of surgical techniques at cesarean, depression during pregnancy, fetal heart rate monitoring and long-term neurologic outcome, randomized clinical trials.
-
Raquel Leanne Lyn
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Lyn serves as a Clinical Assistant Professor within the Division of Pulmonary, Allergy, and Critical Care at Stanford University. Specializing in the comprehensive management of pulmonary hypertension, she completed her fellowship in pulmonary and critical care medicine at Stanford in 2021. She furthered her expertise as the 2021-22 Vera Moulton Wall Center eBay Fellow in Pulmonary Vascular Disease.
Today, Dr. Lyn is a member of the Stanford Health Care Adult Pulmonary Hypertension team, serving as a clinician educator and Assistant Director of the Stanford CTEPH program. Her clinical and research interests focus on CTEPH, post-acute PE care and advancing health equity within pulmonary vascular diseases. -
David Lyons
Professor (Research) of Psychiatry & Behavioral Sciences (General Psychiatry and Psychology-Adult), Emeritus
Current Research and Scholarly InterestsBehavioral neuroscience
-
Michael Lyons
Adjunct Lecturer, Civil and Environmental Engineering
Bio-Co-founded Zilkha Venture Partners; sourced investments that returned 5.8x ; rated Top 5% by Cambridge Associates
-Venture Partner at four other Funds including DFJ/ePlanet I & II, Paladin Capital Group- Deals created $50B+ in market value
-Co-founder, CEO or Chairman or C-Suite of 12 Companies including Integrated Systems (INTS, merged with WIND, acq. by Intel), Shadow Networks acq. by Alcalvio), and CypherPath
(acq. by ManTech); co-founding CEO, SafeView (Acq. By L3-Harris then Leidos) Returned 78% IRR for Series A and 163% IRR for Series B investors
-Currently Chairman PrecisionOSTech (Surgical VR Training); and Turbo Protocol (Web 3 Blockchain ); co-founder & CEO (emeritus), RapidAscent (Cyber Ed); Director RTI, global
leader in IIoT; General Partner, NativeFirst Capital
-Co-founder, Numerous SCPD exec Ed Programs, Idea to Market online program, Price-Babson Fellow in eShip Education
He is also a Managing Director of NewLine Ventures, LLC, a management consulting firm. From 2008 to 2011, he also served as a Venture Partner with the Paladin Capital Group in Washington, D.C., and as a Venture Partner for ePlanet Ventures I and II. He founded SafeView, Inc. in 2002, a Government Laboratory (PNNL) spinout, to address aspects of the anti-terrorist physical security market; He served as Chairman until its sale to L3 Harris in March 2006. Leidos then acquired the Company in 2020. This technology is now the security standard in airports worldwide.
Concurrently, Mr. Lyons is an Adjunct Lecturer at the Stanford University Department of Civil and Environmental Engineering. Serving in the Stanford position since 1988, he was a co-developer of the Stanford Technology Ventures Program with Prof. Tom Byers and the founding professor of Technology Venture Formation. Engineering. He is the co-creator of the Stanford Innovation and Entrepreneurship two-week program for existing high-tech companies produced and managed by the Stanford Center for Professional Development (SCPD). This program has just completed its 14th year. He has co-produced and delivered numerous other SCPD and STVP programs. He co-founded the Ratio Academy focused on creating training platforms for entrepreneurial education, with a co-developed online program with SCPD called Idea to Market, I2M. He is the founding professor of Tech Venture Formation, MSE273.
From 1980 to 1991, he was a co-founder, a Vice-President, and a Director of Integrated Systems Inc. (INTS, founded 1980), a leading implementer of high-performance real-time control systems for aircraft, automotive, and manufacturing applications. INTS was fundamentally a spinout from the Lockheed Palo Alto Research Lab and Systems Control, Inc. The Company was merged with WindRiver Systems in 1999. WindRiver was acquired by Intel in 2009.
Mr. Lyons received a Bachelor and Masters (equivalent) in Engineering Physics from Cornell University, an MSEE from Stanford, did Ph.D research in Aero/Astro at Stanford (abd) and an MBA, with Distinction, from the Pepperdine Presidential/Key Executive Program. He is a graduate of the Stanford/AEA Institute for the Management of High Technology Companies and a Price-Babson Fellow in Entrepreneurship Education. He holds an FAA multi-Engine Airline Transport Pilot License and Certified Flight Instructor Certificates for Instrument and Multi-Engine Aircraft. He is an avid sailor and motorcyclist. -
Zhonglin Lyu
Instructor, Neurosurgery
BioDr. Lyu is an instructor at the Department of Neurosurgery, Stanford University School of Medicine. He obtained his PhD at Soochow University, China, where he gained training in designing biomaterials to modulate stem cell behaviors and led multidisciplinary research under the advice of Prof. Hong Chen. During his PhD, he worked as a visiting student researcher at Canary Center for Early Cancer Detection at Stanford University School of Medicine where he gained training in microfluidics and cancer metastasis. Dr. Lyu carried out his postdoctoral research under the guidance of Prof. Jon Park and Wonjae Lee at the Department of Neurosurgery, Stanford University School of Medicine. He developed an in vitro microphysiological model of ischaemic stroke and used it as a platform to systematically evaluate the restorative potential of stem cell therapy.
As an instructor, Dr. Lyu's main research interest is to develop in vitro tissue/organ models to mimic human diseases including neurological diseases and cancer metastases. The goal is to use these models to understand disease mechanisms, to evaluate the safety and efficacy of existing drugs, and to look for new therapeutic targets. -
Ludmille Lyvert
Ph.D. Student in Education, admitted Autumn 2025
BioLudmille Lyvert is an incoming PhD student in Education at the Stanford Graduate School of Education. Originally from Haiti, she earned her bachelor’s degree in education from Université Quisqueya and completed a master’s degree in Women’s Studies at the University of Alabama in 2025 as a Fulbright Scholar.
With over five years of experience in education and non-profit work, Ludmille is committed to advancing equitable access to education and empowering communities through civic and human rights education. Her research focuses on the intersection of policy studies, program development, and civic and human rights education as a means to inspire social change, particularly in her home country, Haiti.
